Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey.
Fiche publication
Date publication
avril 2017
Journal
Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BARTHELEMY Philippe, Dr BOREL Christian, Dr BURGY Mickaël
Tous les auteurs :
Burgy M, Barthélémy P, Lefevre F, Dupret-Bories A, Truntzer P, Korenbaum C, Flesch H, Bronner G, Borel C
Lien Pubmed
Résumé
The cetuximab plus platinum-based chemotherapy regimen is a standard of care in the treatment of recurrent or metastatic head and neck squamous-cell carcinoma (HNSCC). The feasibility in the elderly population is currently unknown.
Mots clés
Cetuximab, Chemotherapy, Elderly patients, Recurrent or metastatic head and neck squamous-cell carcinoma
Référence
Oncology. 2017 Apr;: